- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02789696
Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome (ACROSAS)
Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome: A Prospective, National and Multicentric Study
Prevalence of sleep apnea syndrome in patients with acromegaly is about 70%. It seems that comorbidities of arterial hypertension or type 2 diabetes are more severe in patients with acromegaly and sleep apnea syndrome. Besides sleep apnea syndrome associated to acromegaly gives rise to few symptoms, that explains it is under diagnosed. The mechanisms of the association are based on maxillofacial modifications linked to acromegaly, a thickening of soft tissues with deposits of glyco-aminoglycanes but probably also because of the associated obesity, of the potential existence of a goiter and a muscular dystrophy of the dilatative muscles of the pharynx.
At present, no study clearly documented prevalence of acromegaly in a diagnostic consultation for sleep apnea syndrome.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
60 investigators will participate to this study. They will be chosen among those participating to the sleep observatory of the federation of pneumology (www.osfp.fr).
All participating pneumologists would have to fill in the questionnaire (co-morbidities, concomitant treatments, biological analysis) directly online and also clinical signs and symptoms of acromegaly. A blood test for the insulin-like growth factor (IGF-1) dosage will be systematically prescribed to the patient. Pneumologists will have to include all consecutive patients presenting with sleep apnea syndrome suspicion.
According to first IGF-1 results, patients may have to do a second blood test in a referenced laboratory to confirm the dosage.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Isère
-
Grenoble, Isère, France, 38700
- University Hospital Grenoble
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Body mass index < 40 kg/m2
- Patient consulting for sleep breathing disorder
- Informed consent signed
- patient covered by french health insurance
Exclusion Criteria:
- Other sleep disorder already diagnosed
- Pregnant women
- Patients participating in an other study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Acromegaly
Diagnosis of acromegaly
|
Biological analysis of IGF-1
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
determination of acromegaly prevalence
Time Frame: 1 year
|
IGF-1 (insulin-like growth factor-1) quantification in blood punction
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
description of clinical signs of acromegaly associated to sleep apnea syndrome (Epworth scale)
Time Frame: 1 year
|
Score to Epworth scale will be compared between patients with sleep apnea syndrome with acromegaly and patients with sleep apnea syndrome only.
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jean-Louis PEPIN, Md, PhD, University Hospital, Grenoble
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Endocrine System Diseases
- Disease
- Musculoskeletal Diseases
- Signs and Symptoms, Respiratory
- Hypothalamic Diseases
- Bone Diseases
- Bone Diseases, Endocrine
- Hyperpituitarism
- Pituitary Diseases
- Sleep Apnea Syndromes
- Syndrome
- Apnea
- Acromegaly
Other Study ID Numbers
- 13CHUG37
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Apnea Syndrome
-
University of ChicagoGlaxoSmithKlineCompletedChildhood Obstructive Sleep Apnea Syndrome (OSAS)United States
-
University Hospital, MontpellierCompletedComplex Sleep Apnea Syndrome | Chronic Heart Failure and | Obstructive Sleep Apnea Syndrome and | Idiopathic Central Sleep Apnea Syndrome | Idiopathic Induced Periodic Breathing | Central Sleep Apnea SyndromeFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingModerate Obstructive Sleep Apnea SyndromeFrance
-
Karolinska University HospitalCompletedObstructive Sleep Apnea Syndrome in ChildrenSweden
-
University of Alabama at BirminghamTerminatedObstructive Sleep Apnea Hypopnea Syndrome (OSAHS)United States
-
Sakarya UniversityUnknown
-
Royal College of Surgeons, IrelandUniversity College Dublin; Connolly Hospital BlanchardstownCompletedObstructive Sleep Apnoea SyndromeIreland
-
Sleepinnov TechnologyUniversity Hospital, Grenoble; ICUREsearchCompletedObstructive Sleep Apnea SyndromeFrance
-
LivaNovaNational Research Agency, FranceCompletedObstructive Sleep Apnea SyndromeFrance
-
Centre Hospitalier de ValenceCompletedObstructive Sleep Apnea/Hypopnea SyndromeFrance
Clinical Trials on Diagnosis of acromegaly
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruiting
-
Ohio State UniversityCorr-Jensen, LLC provided some of the study oil from Arista Industries, IncCompleted
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Icahn...Active, not recruiting
-
NHS Greater Glasgow and ClydeUniversity of GlasgowNot yet recruiting
-
Region Örebro CountyNot yet recruiting
-
Javier López PaisUnknownAmyloidosis Cardiac | Valve Stenoses, AorticSpain
-
CARE Fertility UKUniversity of BirminghamActive, not recruitingInfertility | Adenomyosis | Miscarriage | Pregnancy Loss | ARTUnited Kingdom
-
Hopital ForcillesEnrolling by invitation
-
University Hospital, Strasbourg, FranceUnknown